Search
for
Sort by
Research 871–900 of 1000+
- 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
- 50392 Impact of Baseline Psychiatric and Autoimmune Comorbidities on Economic Burden for Patients in the United States in the First Year After Diagnosis with Alopecia Areata
- 44180 Influence of Baseline Disease Severity Defined by Investigator’s Global Assessment on Abrocitinib Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study
- BH15 The burden of alopecia areata: examining baseline health-related quality of life and clinical assessment tools
- Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
- 75122 Real-world Effectiveness of Baricitinib for Severe Alopecia Areata by Baseline Hair Loss and Episode Duration: Results from a Prospective Observational Study
- Prepared hair oil from Arnica montana- Q in castor and mustard base oil in definite proportion with standardization
- Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a “drug dependency” and a post-finasteride “rebound effect”.
- 723 - Efficacy of ritlecitinib in patients with alopecia areata by extent of hair loss at baseline: post hoc analysis of the phase 3 long-term ALLEGRO-LT study
- Contact allergy to essential oils cannot always be predicted from allergy to fragrance markers in the baseline series
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study
- Results of 60-second timed hair counts in women between the ages of 20–60 years
- Trichoscopic Analysis of Healthy Indian Males for Standardization of the Measurable Parameters: An Observational, Cross-sectional Study
- The use of diphencyprone in dermatology: A retospective audit
- A study of normal eyelashes in Japanese individuals
- 104 Flibanserin Subset Analyses and the Androgenics of Hypoactive Sexual Desire Disorder
- CSF 5-HIAA as a predictor of treatment response in trichotillomania.
- Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa
- Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice
- PD02-05 SRD5A2 EXPRESSION IS A PREDICTOR OF RESPONSE TO FINASTERIDE IN THE MTOPS TRIAL
- Platelet-Rich Plasma as a Treatment for Androgenetic Alopecia
- Supplementation and hair growth: A retrospective chart review of patients with alopecia and laboratory abnormalities
- Platelet-rich Plasma’s Effects in Patients with Androgenetic Alopecia: A Scoping Review
- The Effect of Autologous Activated Platelet Rich Plasma (AA-PRP) Injection on Pattern Hair Loss: Clinical and Histomorphometric Evaluation
- Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss
- The Biological Effects of a Pulsed Electrostatic Field with Specific Reference to Hair Electrotrichogenesis
- Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia
- Nutritional Intervention Alleviates Signs of Dermatological Problems in Dogs by Modulating Immune Regulation and Skin Microbiome
- Iron Supplementation May Improve the Patient’s Level of Satisfaction in Not-Low-Ferritin Telogen Effluvium: A Real-Life Observational Study